Efficacy and Toxicity of Clioquinol Treatment and A-beta42 Inoculation in the APP/PSI Mouse Model of Alzheimer’s Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|10|5|494-506

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.10, Iss.5, 2013-01, pp. : 494-506

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gender dependent APP processing in a transgenic mouse model of Alzheimer’s disease

By Schäfer S.   Wirths O.   Multhaup G.   Bayer T. A.  

Journal of Neural Transmission, Vol. 114, Iss. 3, 2007-03 ,pp. : 387-394

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of CSF-Chlamydia pneumoniae, CSF-tau, and CSF-Abeta42 in Alzheimer’s disease and vascular dementia

By Paradowski Bogusław   Jaremko Malgorzata   Dobosz Tadeusz   Leszek Jerzy   Noga Leszek  

Journal of Neurology, Vol. 254, Iss. 2, 2007-02 ,pp. : 154-159

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Cerebrolysin™ on neurogenesis in an APP transgenic model of Alzheimer’s disease

By Rockenstein Edward   Mante Michael   Adame Anthony   Crews Leslie   Moessler Herbert   Masliah Eliezer  

Acta Neuropathologica, Vol. 113, Iss. 3, 2007-03 ,pp. : 265-275

Springer Publishing Company

Access to resources Recommend Favorite

Enhanced Hippocampal Neurogenesis in APP/Ps1 Mouse Model of Alzheimer’s Disease After Implantation of VEGF-loaded PLGA Nanospheres

By  

Current Alzheimer Research, Vol. 12, Iss. 10, 2015-12 ,pp. : 932-9

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Trichostatin A on Gelsolin Levels, Proteolysis of Amyloid Precursor Protein, and Amyloid Beta-Protein Load in the Brain of Transgenic Mouse Model of Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 11, Iss. 10, 2014-12 ,pp. : 1002-1011

Bentham Science Publishers

Access to resources Recommend Favorite